|
[1]
|
Kazuyuki, S., Motoyuki, I. and Yoriko, T. (2013) Reductive Aldol-Type Reaction of α,β-Unsaturated Esters with Aldehydes or Ketones in the Presence of Rh Catalyst and Et2Zn. Tetrahedron Letters, 54, 5913-5915. [Google Scholar] [CrossRef]
|
|
[2]
|
Banerjee, R., Phan, A. and Wang, B. (2008) High-Throughput Synthesis of Zeolitic Imidazolate Frameworks and Application to CO2 Capture. Science, 319, 939-943. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Sardesai, N.Y., Zimmermann, K. and Barton, J.K. (1994) DNA Recognition by Peptide Complexes of Rhodium (III): Example of a Glutamate Switch. Journal of the American Chemical Society, 116, 7502-7508. [Google Scholar] [CrossRef]
|
|
[4]
|
Lin, R.B., Li, F., Liu, S.Y., Qi, X.L. and Zhang, J.P. (2013) A Noble-Metal-Free Porous Coordination Framework with Exceptional Sensing Efficiency for Oxygen. Angewandte Chemie International Edition, 52, 13429-13433. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Saeed, S., Rashid, N., Jones, P.G., Ali, M. and Hussain, R. (2010) Synthesis, Characterization and Biological Evaluation of Some Thiourea Derivatives Bearing Benzothiazole Moiety as Potential Antimicrobial and Anticancer Agents. European Journal of Medicinal Chemistry, 45, 1323-1331. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Liang, J.-X., et al. (2017) Recent Development of Transition Metal Complexes with in Vivo Antitumor Activity. Journal of Inorganic Biochemistry, 177, 276-286. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Sun, R., et al. (2011) Luminescent Cyclometalated Platinum (II) Complexes Containing N-Heterocyclic Carbene Ligands with Potent in Vitro and in Vivo Anti-Cancer Properties Accumulate in Cytoplasmic Structures of Cancer Cells. Chemical Science, 2, 728-736. [Google Scholar] [CrossRef]
|
|
[8]
|
Frik, M., et al. (2014) In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium (II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer. Journal of Medicinal Chemistry, 57, 9995-10012. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Yang, C., et al. (2016) Discovery of a VHL and HIF1α Interaction Inhibitor with in Vivo Angiogenic Activity via Structure-Based Virtual Screening. Chemical Communications, 52, 12837-12840. [Google Scholar] [CrossRef]
|
|
[10]
|
Lum, C.T., et al. (2014) Gold (III) Complexes Inhibit Growth of Cisplatin-Resistant Ovarian Cancer in Association with Upregulation of Proapoptotic PMS2 Gene. Chemical Science, 5, 1579-1584. [Google Scholar] [CrossRef]
|
|
[11]
|
Gramatica, P. (2007) Principles of QSAR Models Validation: Internal and External. QSAR & Combinatorial Science, 26, 694-701. [Google Scholar] [CrossRef]
|
|
[12]
|
Lau, J. and Ensing, B. (2010) Hydrolysis of Cisplatin—A First-Principles Metadynamics Study. Physical Chemistry Chemical Physics, 35, 10348-10355. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Lau, J.K.C. and Deubel, D.V. (2006) Hydrolysis of the Anticancer Drug Cisplatin: Pitfalls in the Interpretation of Quantum Chemical Calculations. Journal of Chemical Theory and Computation, 2, 103-106. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Tai, T.B. and Nhat, P.V. (2017) A DFT Investigation on Interactions between Asymmetric Derivatives of Cisplatin and Nucleobase Guanine. Chemical Physics Letters, 680, 44-50. [Google Scholar] [CrossRef]
|
|
[15]
|
Graziani, V., Coletti, C., Marrone, A. and Re, N. (2016) Activation and Reactivity of a Bispidine Analogue of Cisplatin: A Theoretical Investigation. The Journal of Physical Chemistry A, 120, 5175-5186. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Baik, M.H., Friesner, R.A. and Lippard, S.J. (2003) Theoretical Study of Cisplatin Binding to Purine Bases: Why Does Cisplatin Prefer Guanine over Adenine? Journal of the American Chemical Society, 125, 14082-14092. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Alberto, M.E., Lucas, M.F.A., Pavelka, M. and Russo, N. (2009) The Second-Generation Anticancer Drug Nedaplatin: A Theoretical Investigation on the Hydrolysis Mechanism. The Journal of Physical Chemistry B, 113, 14473-14479. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Pavelka, M., Lucas, M.F.A. and Russo, N. (2007) On the Hydrolysis Mechanism of the Second-Generation Anticancer Drug Carboplatin. Chemistry—A European Journal, 13, 10108-10116. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Kuduk-Jaworska, J., Jański, J.J. and Roszak, S. (2017) Comparative Study of Hydrolytic and Electron-Driven Processes in Carboplatin Biotransformation. Journal of Inorganic Biochemistry, 170, 148-159. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Rezazadeh, M., Ghiasi, R. and Jamehbozorgi, S. (2018) Solvent Effects on the Structure and Spectroscopic Properties of the Second-Generation Anticancer Drug Carboplatin: A Theoretical Insight. Journal of Structural Chemistry, 59, 245-251. [Google Scholar] [CrossRef]
|
|
[21]
|
Lucas, M.F.A., Pavelka, M., Alberto, M.E. and Russo, N. (2008) Neutral and Acidic Hydrolysis Reactions of the Third Generation Anticancer Drug Oxaliplatin. The Journal of Physical Chemistry B, 113, 831-838. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Cerón-Carrasco, J.P., Cerezo, J. and Requena, A. (2014) Labelling Herceptin with a Novel Oxaliplatin Derivative: A Computational Approach towards the Selective Drug Delivery. Journal of Molecular Modeling, 20, 2401. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Mutter, S.T. and Platts, J.A. (2011) Density Functional Theory Studies of Interactions of Ruthenium-Arene Complexes with Base Pair Steps. The Journal of Physical Chemistry A, 115, 11293-11302. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Chen, J.C., Chen, L.M., Xu, L.C., Zheng, K.C. and Ji, L.N. (2008) Binding to DNA Purine Base and Structure—Activity Relationship of a Series of Structurally Related Ru (II) Antitumor Complexes: A Theoretical Study. The Journal of Physical Chemistry B, 112, 9966-9974. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Mir, J.M., Jain, N., Jaget, P.S. and Maurya, R.C. (2017) Density Functionalized [RuII (NO)(Salen)(Cl)] Complex: Computational Photodynamics and in Vitro Anticancer Facets. Photodiagnosis and Photodynamic Therapy, 19, 363-374. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Chen, J., Chen, L., Liao, S. and Zheng, K. (2007) A Theoretical Study on the Hydrolysis Process of the Antimetastatic Ruthenium (III) Complex NAMI-A. The Journal of Physical Chemistry B, 111, 7862-7869. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Alvarado-Soto, L. and Ramirez-Tagle, R. (2015) A Theoretical Study of the Binding of [Re6Se8(OH)2(H2O)4] Rhenium Clusters to DNA Purine Base Guanine. Materials, 8, 3938-3944. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Sayin, K. and Üngördü, A. (2018) Investigation of Anticancer Properties of Caffeinated Complexes via Computational Chemistry Methods. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 193, 147-155. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Galindo-Murillo, R., Ruíz-Azuara, L., Moreno-Esparza, R. and Cortés-Guzmán, F. (2012) Molecular Recognition between DNA and a Copper-Based Anticancer Complex. Physical Chemistry Chemical Physics, 14, 15539-15546. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Deubel, D.V. and Chifotides, H.T. (2007) Guanine Binding to Dirhodium Tetracarboxylate Anticancer Complexes: Quantum Chemical Calculations Unravel an Elusive Mechanism. Chemical Communications, 33, 3438-3440. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Rafi, U.M., Mahendiran, D., Haleel, A.K. and Nankar, R.P. (2016) New Pyridazine-Based Binuclear Nickel (II), Copper (II) and Zinc (II) Complexes as Prospective Anticancer Agents. New Journal of Chemistry, 40, 2451-2465. [Google Scholar] [CrossRef]
|
|
[32]
|
Šponer, J.E., Leszczynski, J. and Šponer, J. (2006) Mechanism of Action of Anticancer Titanocene Derivatives: An Insight from Quantum Chemical Calculations. The Journal of Physical Chemistry B, 110, 19632-19636. [Google Scholar] [CrossRef] [PubMed]
|